Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Implantica AG

Capitalization 1.11B 1.28B 1B 956M 1.74B 118B 1.79B 11.82B 4.71B 56.5B 4.81B 4.71B 203B P/E ratio 2025
-16.5x
P/E ratio 2026 * -10.8x
Enterprise value 1.06B 1.23B 956M 914M 1.67B 113B 1.71B 11.3B 4.5B 54.03B 4.6B 4.5B 195B EV / Sales 2025
633x
EV / Sales 2026 * 322x
Free-Float
4.86%
Yield 2025 *
-
Yield 2026 * -
1 day-2.64%
1 week-8.78%
Current month-11.96%
1 month-11.96%
3 months-21.66%
6 months-38.45%
Current year-19.16%
1 week 39.8
Extreme 39.8
45.15
1 month 39.8
Extreme 39.8
49.85
Current year 39.8
Extreme 39.8
55
1 year 22
Extreme 22
86.4
3 years 15.4
Extreme 15.4
86.4
5 years 15.4
Extreme 15.4
136.8
10 years 15.4
Extreme 15.4
178.9
Manager TitleAgeSince
Chief Executive Officer 72 31/12/2014
Director of Finance/CFO 48 31/12/2019
Corporate Officer/Principal 69 -
Director TitleAgeSince
Director/Board Member 71 31/12/2019
Chairman 67 31/12/2019
Director/Board Member 62 31/12/2019
Change 5d. change 1-year change 3-years change Capi.($)
-2.64%-8.78%+21.62%+48.08% 1.29B
-0.37%-1.17%+27.93%+33.14% 13.21B
-0.01%+0.05%+5.37%-0.11% 9.16B
-1.15%-3.36%-9.45%-13.43% 5.81B
-0.65%-2.70%+31.58%+36.42% 5.44B
-0.68%-0.71%-2.62%+13.47% 5.33B
-1.58%0.00% - - 5.15B
+1.51%-0.51%-7.74%+45.74% 4.75B
+1.74%+10.63%+16.06%-49.31% 1.83B
-1.33%-6.71%-41.28%-81.59% 1.45B
Average -0.52%+0.44%+4.61%+3.60% 5.34B
Weighted average by Cap. -0.41%+0.09%+9.98%+14.49%

Financials

2025 2026 *
Net sales 2.04M 2.37M 1.85M 1.77M 3.22M 218M 3.31M 21.82M 8.7M 104M 8.88M 8.69M 376M 3.36M 3.89M 3.04M 2.9M 5.29M 359M 5.44M 35.89M 14.31M 172M 14.6M 14.3M 618M
Net income -17.96M -20.79M -16.22M -15.51M -28.27M -1.92B -29.06M -192M -76.41M -917M -77.99M -76.35M -3.3B -25.25M -29.22M -22.8M -21.8M -39.74M -2.69B -40.86M -269M -107M -1.29B -110M -107M -4.64B
Net Debt -48.38M -55.99M -43.68M -41.77M -76.14M -5.16B -78.29M -516M -206M -2.47B -210M -206M -8.89B -22.78M -26.37M -20.57M -19.67M -35.86M -2.43B -36.87M -243M -96.92M -1.16B -98.93M -96.85M -4.19B
Logo Implantica AG
Implantica AG is Lichtenstein-based medical technology Company, whose mission is to provide effective treatment for serious health conditions and to improve patients' life through the use of advanced technologies in the human body, ultimately aiming to reduce costs and increase efficiency in the healthcare System. The therapies developed by Implantica are based on implants that are inserted into the patient's body and remain in the body permanently or semi-permanently to replace bodily functions and/or treat diseases. The Company focuses on the discovery, development and prospective commercialization of medical products and implants that are intended for use in different treatment fields like in the area of gastrointestinal surgery and urology. The Company's lead product is RefluxStop, a passive, implant to prevent gastroesophageal reflux disease (GERD).
Employees
-
Date Price Change Volume
11/03/26 40.50 kr -2.64% 31,941
10/03/26 41.60 kr +1.22% 74,143
09/03/26 41.10 kr -3.29% 46,809
06/03/26 42.50 kr -2.86% 41,173
05/03/26 43.75 kr -1.46% 35,038
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.907EUR
Average target price
6.848EUR
Spread / Average Target
+75.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. IMP A SDB Stock
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW